Aarhus University Hospital

Molecule prevents effect of chemotherapy

Researchers at Aarhus University Hospital found a molecule associated with Oxaliplatin treatment resistance, where patients with high levels have a six times higher risk of not responding to the drug. Eliminating this microRNA biomarker from tumors may restore sensitivity to Oxaliplatin-based chemotherapy.

SourceAarhus University Hospital·JournalNature Communications·DateAug 16, 2016

New research paves the way for improved individual treatment of patients with cancer

Researchers have identified three primary molecular sub-groups of bladder cancer, with distinct characteristics and disease-developing patterns. The findings may enable more effective risk assessment and tailored treatment options for patients with superficial tumours.

SourceAarhus University Hospital·JournalCancer Cell·DateJun 17, 2016